◆英語タイトル:Point of Care Diagnostics - Current and Future Players
Single UserUSD3,500 ⇒換算¥388,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,385 ⇒換算¥597,735見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD8,300 ⇒換算¥921,300見積依頼/購入/質問フォーム

Point of Care Diagnostics – Current and Future Players

The Point-Of-Care (POC) market is very fragmented with over 100 players currently marketing POC products in their portfolio, thus competition and pricing pressures in the development and marketing of POC diagnostic devices is intense. There are a large number of multinational and regional competitors making investments in competing technologies and products, including several large pharmaceutical and diversified healthcare companies. The competitive factors in the POC space include fast TAT of test results, price, reimbursement, data handling techniques, and analytical performance as well as the R&D, distribution, marketing, promotion and brand name recognition of the company.

The report provides up-to-date information and in-depth analysis on the key players that shape the global POC diagnostics market. The report also includes analysis of company profiles, industry trends, and corporate strategy. This report is built using data and information sourced from secondary sources and primary research interviews with Key Opinion Leaders.

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.


- Investigation of current and future market competition in the POC diagnostics market.
- Competitive Assessment including product profiles.
- Pipeline Assessment including 82 pipeline products.
- Coverage of key market players, which includes company profiles, business descriptions, financial overviews, portfolio assessments, and SWOT analyses.
- Strategic Assessment of the market through market impact analysis, future market scenario, and company analysis.

Reasons to buy

- Gain a high level view of the trends shaping and driving the POC diagnostics market.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Executive Summary
2.1 Key Players in the POC Diagnostics Market
3 Introduction
3.1 Catalyst
3.2 Related Reports
4 Industry Overview
4.1 POC Diagnostics Overview
4.2 Mergers, Acquisitions, and Key Partnerships
5 Competitive Assessment
5.1 Company Share Analysis
5.1.1 Global
5.1.2 US
5.1.3 Europe
5.1.4 Asia-Pacific
5.2 Trends in Corporate Strategy
5.3 Major Players
5.3.1 Abbott Diagnostics
5.3.2 Akers Bioscience
5.3.3 Alere
5.3.4 Beckman Coulter
5.3.5 BioMerieux
5.3.6 Chembio Diagnostics
5.3.7 EKF Diagnostics
5.3.8 Meridian Bioscience
5.3.9 OraSure Technologies
5.3.10 Quidel
5.3.11 Radiometer Medical
5.3.12 Response Biomedical
5.3.13 Roche Diagnostics
5.3.14 Siemens Healthcare
5.3.15 Trinity Biotech
5.3.16 Other Companies
6 Pipeline Assessment
6.1 Overview
6.2 Pipeline Profiles
6.2.1 Cardiac Markers POCT
6.2.2 Female Fertility and Pregnancy POCT
6.2.3 Hematology POCT
6.2.4 Infectious Disease POCT
6.2.5 Immunochemistry POCT Analyzers
7 Appendix
7.1 Bibliography
7.2 Abbreviations
7.3 Report Methodology
7.3.1 Overview
7.3.2 Coverage
7.3.3 Secondary Research
7.3.4 Forecasting Methodology
7.3.5 Primary Research — Key Opinion Leader Interviews
7.3.6 Primary Research – Physician and Industry Interviews
7.3.7 Expert Panel Validation
7.4 Physicians and Specialists Included in This Study
7.5 About the Authors
7.5.1 Analysts
7.5.2 Tyler Fletcher, Global Head of Medical Devices
7.6 About MediPoint
7.7 About GlobalData
7.8 Contact Us
7.9 Disclaimer

1.1 List of Tables
Table 1: Advantages and Disadvantages of POCT
Table 2: Mergers, Acquisitions, and Key Partnerships, 2012-2016
Table 3: Company Profile - Abbott Diagnostics
Table 4: Abbott Diagnostics’ POC Portfolio Assessment, 2015
Table 5: SWOT Analysis - Abbott Diagnostics
Table 6: Company Profile - Akers Bioscience
Table 7: Aker Bioscience’s POC Portfolio Assessment, 2015
Table 8: SWOT Analysis - Akers Bioscience
Table 9: Company Profile - Alere
Table 10: Alere’s POC Portfolio Assessment, 2015
Table 11: SWOT Analysis - Alere
Table 12: Company Profile - Beckman Coulter
Table 13: Beckman Coulter’s POC Portfolio Assessment, 2015
Table 14: SWOT Analysis - Beckman Coulter
Table 15: Company Profile - BioMerieux
Table 16: BioMerieux’s POC Portfolio Assessment, 2015
Table 17: SWOT Analysis - BioMerieux
Table 18: Company Profile - Chembio Diagnostics
Table 19: Chembio Diagnostics’ POC Portfolio Assessment, 2015
Table 20: SWOT Analysis - Chembio Diagnostics
Table 21: Company Profile - EKF Diagnostics
Table 22: EKF Diagnostics’ POC Portfolio Assessment, 2015
Table 23: SWOT Analysis - EKF Diagnostics
Table 24: Company Profile - Meridian Bioscience
Table 25: Meridian Bioscience’s POC Portfolio Assessment, 2015
Table 26: SWOT Analysis - Meridian Bioscience
Table 27: Company Profile - OraSure Technologies
Table 28: OraSure Technologies’ POC Portfolio Assessment, 2015
Table 29: SWOT Analysis - OraSure Technologies
Table 30: Company Profile - Quidel
Table 31: Quidel’s POC Portfolio Assessment, 2015
Table 32: SWOT Analysis - Quidel
Table 33: Company Profile - Radiometer Medical
Table 34: Radiometer Medical’s POC Portfolio Assessment, 2015
Table 35: SWOT Analysis - Radiometer Medical
Table 36: Company Profile - Response Biomedical
Table 37: Response Biomedical’s POC Portfolio Assessment, 2015
Table 38: SWOT Analysis - Response Biomedical
Table 39: Company Profile - Roche Diagnostics
Table 40: Roche Diagnostics’ POC Portfolio Assessment, 2015
Table 41: SWOT Analysis - Roche Diagnostics
Table 42: Company Profile - Siemens Healthcare
Table 43: Siemens Healthcare’s POC Portfolio Assessment, 2015
Table 44: SWOT Analysis - Siemens Healthcare
Table 45: Company Profile - Trinity Biotech
Table 46: Trinity Biotech’s POC Portfolio Assessment, 2015
Table 47: SWOT Analysis - Trinity Biotech
Table 48: Other POC Companies in North America, 2015
Table 49: Other POC Companies in Europe, 2015
Table 50: Other POC Companies in APAC and Other Regions, 2015
Table 51: Key Cardiac Markers POCT Pipelines, 2015
Table 52: Key Female Fertility and Pregnancy POCT Pipelines, 2015
Table 53: Key Hematology POCT Pipelines, 2015
Table 54: Key Infectious Disease POCT Pipelines, 2015
Table 55: Key Immunochemistry POCT Analyzer Pipelines, 2015

1.2 List of Figures
Figure 1: Global POC Diagnostics Market, By Company Share, 2015
Figure 2: US POC Diagnostics Market, By Company Share, 2015
Figure 3: Europe POC Diagnostics Market, By Company Share, 2015
Figure 4: APAC POC Diagnostics Market, By Company Share, 2015


Abbott Diagnostics
Akers Bioscience
Beckman Coulter
Chembio Diagnostics
EKF Diagnostics
Meridian Bioscience
OraSure Technologies
Radiometer Medical
Response Biomedical
Roche Diagnostics
Siemens Healthcare
Trinity Biotech